| 46 |
ZBTB16::RARA variant acute promyelocytic leukemia (vAPL) treated with gemtuzumab ozogamicin (GO) with unique pathology and genetic findings |
Department of Clinical Pathology |
2023 |
| 47 |
Graves’ disease in children: an update |
Department of Pediatrics |
2023 |
| 48 |
The Role of Prothrombin Gene and Methylenetetrahydrofolate Reductase 1 Gene Polymorphisms and Thrombophilia Markers as Risk Factors for 2 Recurrent unexplained Miscarriage |
Department of Clinical Pathology |
2023 |
| 49 |
Immune Modulation of Inflammasome Stimulates NLRP3 and IL-1β Expression in Preeclampsia: Insights into the Role of Anti-Inflammatory Agents in Prevention of Low Birth Weight |
Department of Obstetrics and Gynecology |
2023 |
| 50 |
Non-invasive carbon dioxide monitoring during moderate sedation at different oxygen flow rates in patients undergoing endoscopic retrograde cholangio-pancreatography |
Department of Anesthesia and Intensive Care |
2023 |
| 51 |
Prognostic value of echocardiographic indices in risk stratification of intermediate‑risk pulmonary embolism |
Department of Chest Diseases |
2023 |
| 52 |
Association between periodontitis and cardiovascular health in rheumatoid arthritis patients: Prospective effect of periodontal treatment on cardiovascular risk |
Department of Diagnostic Radiology |
2023 |
| 53 |
Umbilical Cord Length Index as a New Ultrasonographic Method for Prediction of Cord Abnormalities before Delivery |
Department of Obstetrics and Gynecology |
2023 |
| 54 |
Intermittent treatment with Apremilast, a phosphodiesterase-4 inhibitor, ameliorates Alzheimer’s-like pathology and symptoms through multiple targeting actions in aged T2D rats |
Department of Pharmacology |
2023 |
